Corbus Pharmaceuticals Holdings, Inc. Operating Income
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Operating Income of -$36.19 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- Corbus Pharmaceuticals Holdings, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$36.19M.
- Corbus Pharmaceuticals Holdings, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$24.30M.
- Corbus Pharmaceuticals Holdings, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$21.97M.
- Corbus Pharmaceuticals Holdings, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$24.42M.
- Corbus Pharmaceuticals Holdings, Inc. operating income (loss) for fiscal 2025 was -$85.31M.
- Corbus Pharmaceuticals Holdings, Inc. operating income (loss) for fiscal 2024 was -$48.72M.
- Corbus Pharmaceuticals Holdings, Inc. operating income (loss) for fiscal 2023 was -$45.08M.
- Corbus Pharmaceuticals Holdings, Inc. operating income (loss) for fiscal 2022 was -$39.84M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$36.19M 10-Q · filed 2026-08-06 | -$60.49M 10-Q · filed 2026-08-06 | -$82.46M derived: sum of 3 quarters · filed 2026-08-06 | -$106.88M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$24.30M 10-Q · filed 2026-05-12 | -$46.27M derived: sum of 2 quarters · filed 2026-05-12 | -$70.69M derived: sum of 3 quarters · filed 2026-05-12 | -$89.84M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$21.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$46.38M derived: sum of 2 quarters · filed 2026-03-09 | -$65.53M derived: sum of 3 quarters · filed 2026-08-06 | -$85.31M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | -$24.42M 10-Q · filed 2025-11-12 | -$43.57M derived: sum of 2 quarters · filed 2026-08-06 | -$63.34M 10-Q · filed 2025-11-12 | -$75.95M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$19.15M 10-Q · filed 2026-08-06 | -$38.93M 10-Q · filed 2026-08-06 | -$51.53M derived: sum of 3 quarters · filed 2026-08-06 | -$67.04M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$19.77M 10-Q · filed 2026-05-12 | -$32.38M derived: sum of 2 quarters · filed 2026-05-12 | -$47.88M derived: sum of 3 quarters · filed 2026-05-12 | -$58.87M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | -$12.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$28.11M derived: sum of 2 quarters · filed 2026-03-09 | -$39.10M derived: sum of 3 quarters · filed 2026-03-09 | -$48.72M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | -$15.51M 10-Q · filed 2025-11-12 | -$26.49M derived: sum of 2 quarters · filed 2025-11-12 | -$36.12M 10-Q · filed 2025-11-12 | -$46.22M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | -$10.99M 10-Q · filed 2025-08-05 | -$20.61M 10-Q · filed 2025-08-05 | -$30.71M derived: sum of 3 quarters · filed 2025-08-05 | -$40.20M derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | -$9.62M 10-Q · filed 2025-05-06 | -$9.62M 10-Q · filed 2024-05-07 | -$19.73M derived: sum of 2 quarters · filed 2025-05-06 | -$29.21M derived: sum of 3 quarters · filed 2025-05-06 | -$37.40M derived: sum of 4 quarters · filed 2025-05-06 | |||
| 2023-12-31 | -$10.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$19.59M derived: sum of 2 quarters · filed 2025-03-11 | -$27.78M derived: sum of 3 quarters · filed 2025-03-11 | -$45.08M 10-K · filed 2025-03-11 | -$45.08M 10-K · filed 2024-03-12 | |||
| 2023-09-30 | -$9.49M 10-Q · filed 2024-11-07 | -$9.49M 10-Q · filed 2023-11-07 | -$17.68M derived: sum of 2 quarters · filed 2024-11-07 | -$34.97M 10-Q · filed 2024-11-07 | -$34.97M 10-Q · filed 2023-11-07 | -$45.77M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | -$8.19M 10-Q · filed 2024-08-06 | -$8.19M 10-Q · filed 2023-08-08 | -$25.49M 10-Q · filed 2024-08-06 | -$25.49M 10-Q · filed 2023-08-08 | -$36.28M derived: sum of 3 quarters · filed 2024-08-06 | -$44.46M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | -$17.30M 10-Q · filed 2024-05-07 | -$28.09M derived: sum of 2 quarters · filed 2024-05-07 | -$36.28M derived: sum of 3 quarters · filed 2024-05-07 | -$48.62M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | -$10.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$18.98M derived: sum of 2 quarters · filed 2024-03-12 | -$31.32M derived: sum of 3 quarters · filed 2024-03-12 | -$39.84M 10-K · filed 2024-03-12 | ||||
| 2022-09-30 | -$8.18M 10-Q · filed 2023-11-07 | -$20.52M derived: sum of 2 quarters · filed 2023-11-07 | -$29.04M 10-Q · filed 2023-11-07 | -$39.04M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | -$12.34M 10-Q · filed 2023-08-08 | -$20.86M 10-Q · filed 2023-08-08 | -$30.86M derived: sum of 3 quarters · filed 2023-08-08 | -$44.73M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | -$8.52M 10-Q · filed 2023-05-09 | -$18.52M derived: sum of 2 quarters · filed 2023-05-09 | -$32.39M derived: sum of 3 quarters · filed 2023-05-09 | -$49.09M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | -$10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$23.87M derived: sum of 2 quarters · filed 2023-03-07 | -$40.57M derived: sum of 3 quarters · filed 2023-03-07 | -$55.99M 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | -$13.88M 10-Q · filed 2022-11-08 | -$30.58M derived: sum of 2 quarters · filed 2022-11-08 | -$45.99M 10-Q · filed 2022-11-08 | -$66.80M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$16.70M 10-Q · filed 2022-08-09 | -$32.12M 10-Q · filed 2022-08-09 | -$52.93M derived: sum of 3 quarters · filed 2022-08-09 | -$86.90M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$15.41M 10-Q · filed 2022-05-10 | -$36.23M derived: sum of 2 quarters · filed 2022-05-10 | -$70.20M derived: sum of 3 quarters · filed 2022-05-10 | -$108.34M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | -$20.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$54.79M derived: sum of 2 quarters · filed 2022-03-08 | -$92.92M derived: sum of 3 quarters · filed 2022-03-08 | -$122.81M 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | -$33.97M 10-Q · filed 2021-11-12 | -$72.11M derived: sum of 2 quarters · filed 2021-11-12 | -$102.00M 10-Q · filed 2021-11-12 | -$129.19M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | -$38.14M 10-Q · filed 2021-08-12 | -$68.02M 10-Q · filed 2021-08-12 | -$95.21M derived: sum of 3 quarters · filed 2021-08-12 | -$120.31M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$29.89M 10-Q · filed 2021-05-13 | -$57.08M derived: sum of 2 quarters · filed 2021-05-13 | -$82.17M derived: sum of 3 quarters · filed 2021-05-13 | -$80.47M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$27.19M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$52.29M derived: sum of 2 quarters · filed 2021-03-15 | -$50.58M derived: sum of 3 quarters · filed 2021-03-15 | -$77.10M 10-K · filed 2021-03-15 | ||||
| 2019-09-30 | -$25.10M 10-Q · filed 2020-11-09 | -$23.39M derived: sum of 2 quarters · filed 2020-11-09 | -$49.91M 10-Q · filed 2020-11-09 | -$67.51M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $1.71M 10-Q/A · filed 2020-08-31 | -$24.82M 10-Q/A · filed 2020-08-31 | -$42.41M derived: sum of 3 quarters · filed 2020-08-31 | -$57.31M derived: sum of 4 quarters · filed 2020-08-31 | ||||
| 2019-03-31 | -$26.52M 10-Q · filed 2020-05-11 | -$44.11M derived: sum of 2 quarters · filed 2020-05-11 | -$59.01M derived: sum of 3 quarters · filed 2020-05-11 | -$71.41M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | -$17.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$32.49M derived: sum of 2 quarters · filed 2020-03-16 | -$44.88M derived: sum of 3 quarters · filed 2020-03-16 | -$56.75M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | -$14.90M 10-Q · filed 2019-11-07 | -$27.29M derived: sum of 2 quarters · filed 2019-11-07 | -$39.16M 10-Q · filed 2019-11-07 | -$50.02M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$12.39M 10-Q · filed 2019-08-08 | -$24.26M 10-Q · filed 2019-08-08 | -$35.12M derived: sum of 3 quarters · filed 2019-08-08 | -$42.08M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$11.86M 10-Q · filed 2019-05-09 | -$22.73M derived: sum of 2 quarters · filed 2019-05-09 | -$29.68M derived: sum of 3 quarters · filed 2019-05-09 | -$36.98M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | -$10.86M 10-K · filed 2018-03-12 | -$17.82M derived: sum of 2 quarters · filed 2018-11-08 | -$25.11M derived: sum of 3 quarters · filed 2018-11-08 | -$32.56M 10-K · filed 2019-03-12 | ||||
| 2017-09-30 | -$6.96M 10-Q · filed 2018-11-08 | -$14.25M derived: sum of 2 quarters · filed 2018-11-08 | -$21.70M 10-Q · filed 2018-11-08 | -$29.27M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | -$7.29M 10-Q · filed 2018-08-08 | -$14.74M 10-Q · filed 2018-08-08 | -$22.32M derived: sum of 3 quarters · filed 2018-08-08 | -$27.65M derived: sum of 4 quarters · filed 2018-08-08 | ||||
| 2017-03-31 | -$7.45M 10-K · filed 2018-03-12 | -$15.02M derived: sum of 2 quarters · filed 2018-05-10 | -$20.36M derived: sum of 3 quarters · filed 2018-05-10 | -$24.55M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | -$7.57M 10-K · filed 2018-03-12 | -$12.91M derived: sum of 2 quarters · filed 2018-03-12 | -$17.10M derived: sum of 3 quarters · filed 2018-03-12 | -$19.99M 10-K · filed 2018-03-12 | ||||
| 2016-09-30 | -$5.33M 10-K · filed 2018-03-12 | -$9.53M derived: sum of 2 quarters · filed 2018-03-12 | -$12.41M 10-Q · filed 2017-11-08 | -$14.91M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-06-30 | -$4.19M 10-K · filed 2018-03-12 | -$7.08M 10-Q · filed 2017-08-09 | -$9.58M derived: sum of 3 quarters · filed 2018-03-12 | -$11.83M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-03-31 | -$2.89M 10-K · filed 2018-03-12 | -$5.39M derived: sum of 2 quarters · filed 2018-03-12 | -$7.64M derived: sum of 3 quarters · filed 2018-03-12 | -$10.21M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2015-12-31 | -$2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$4.76M derived: sum of 2 quarters · filed 2018-03-12 | -$7.32M derived: sum of 3 quarters · filed 2018-03-12 | -$8.85M 10-K · filed 2018-03-12 | ||||
| 2015-09-30 | -$2.25M 10-Q · filed 2016-11-10 | -$4.82M derived: sum of 2 quarters · filed 2016-11-10 | -$6.35M 10-Q · filed 2016-11-10 | -$7.61M derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | -$2.56M 10-Q · filed 2016-08-12 | -$4.10M 10-Q · filed 2016-08-12 | -$5.36M derived: sum of 3 quarters · filed 2016-08-12 | -$6.18M derived: sum of 4 quarters · filed 2016-08-12 | ||||
| 2015-03-31 | -$1.54M 10-Q · filed 2016-05-13 | -$2.79M derived: sum of 2 quarters · filed 2016-05-13 | -$3.61M derived: sum of 3 quarters · filed 2016-05-13 | -$4.08M derived: sum of 4 quarters · filed 2016-05-13 | ||||
| 2014-12-31 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | -$2.08M derived: sum of 2 quarters · filed 2016-03-28 | -$2.54M derived: sum of 3 quarters · filed 2016-03-28 | -$2.65M 10-K · filed 2016-03-28 | ||||
| 2014-09-30 | -$818.20K 10-Q · filed 2015-11-10 | -$1.28M derived: sum of 2 quarters · filed 2015-11-10 | -$1.39M 10-Q · filed 2015-11-10 | -$1.66M derived: sum of 4 quarters · filed 2015-11-10 | ||||
| 2014-06-30 | -$464.30K 10-Q · filed 2015-08-13 | -$569.94K 10-Q · filed 2015-08-13 | -$846.20K derived: sum of 3 quarters · filed 2015-08-13 | -$891.54K derived: sum of 4 quarters · filed 2015-08-13 | ||||
| 2014-03-31 | -$105.64K 10-Q · filed 2015-05-13 | -$381.90K derived: sum of 2 quarters · filed 2015-05-13 | -$427.25K derived: sum of 3 quarters · filed 2015-05-13 | |||||
| 2013-12-31 | -$276.26K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-10 | -$321.60K derived: sum of 2 quarters · filed 2015-02-10 | -$557.28K 10-K · filed 2015-02-10 | |||||
| 2013-09-30 | -$45.34K 10-Q · filed 2014-11-13 | -$281.02K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |